The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Wave Life Sciences Ltd shares valued at $112,080 were purchased by ADRIAN RAWCLIFFE on Nov 13 ’25. At $6.96 per share, ADRIAN RAWCLIFFE acquired 16,115 shares.
Also, Verdine Gregory L. sold 10,000 shares, netting a total of over 100,000 in proceeds. Following the sale of shares at $10.00 each, the insider now holds 285,217 shares.
Before that, BOLNO PAUL had sold 217,351 shares from its account. In a trade valued at $2,194,810, the President and CEO traded Wave Life Sciences Ltd shares for $10.10 each. Upon closing the transaction, the insider’s holdings decreased to 217,351 shares, worth approximately $0.81 million.
As published in their initiating research note from Wells Fargo on October 20, 2025, Wave Life Sciences Ltd [WVE] has been an Overweight and the price target has been revised to $18. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in early August. As of July 28, 2025, Oppenheimer has initiated its “an Outperform” rating for WVE. Earlier on July 16, 2025, Citigroup initiated its rating. Their recommendation was “a Buy” for WVE stock.
Analyzing WVE Stock Performance
On last trading session, Wave Life Sciences Ltd [NASDAQ: WVE] plunged -4.10% to $6.67. The stock’s lowest price that day was $6.62, but it reached a high of $7.26 in the same session. During the last five days, there has been a drop of approximately -15.36%. Over the course of the year, Wave Life Sciences Ltd shares have dropped approximately -59.43%. Shares of the company reached a 52-week high of $13.92 on 01/03/25 and a 52-week low of $5.28 on 04/09/25.
Support And Resistance Levels for Wave Life Sciences Ltd (WVE)
According to the 24-hour chart, there is a support level at 6.44, which, if violated, would cause prices to drop to 6.21. In the upper region, resistance lies at 7.08. The next price resistance is at 7.49. RSI (Relative Strength Index) is 37.49 on the 14-day chart, showing neutral technical sentiment.
Is Wave Life Sciences Ltd subject to short interest?
Stocks of Wave Life Sciences Ltd saw a sharp steep in short interest on 2025-10-31 dropping by -2.48 million shares to 13.37 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 15.85 million shares. A decline of -18.56% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.22 of the overall float, the days-to-cover ratio (short ratio) decline to 4.22.
Which companies own the most shares of Wave Life Sciences Ltd (WVE)?
In terms of Wave Life Sciences Ltd share price expectations, FactSet research, analysts set an average price target of 18 in the next 12 months, up nearly 158.99% from the previous closing price of $6.95. Analysts anticipate Wave Life Sciences Ltd stock to reach 26 by 2025, with the lowest price target being 12. In spite of this, 3 analysts ranked Wave Life Sciences Ltd stock as Buy at the end of 2025. On June 11, 2025, Raymond James assigned a price target of “an Outperform” to the stock and resumed coverage with a $14.
